%0 Journal Article
%T STAT1、CXCL9及AR在三阴性乳腺癌中的表达及临床病理意义<br>Expression and Clinicopathological Significance of STAT1, CXCL9 and AR in Triple Negative Breast Cancer
%A 孟婷
%A 曾满芹
%A 董娴宁
%A 赵静
%A 王成勤
%A 魏志敏
%J Advances in Clinical Medicine
%P 1378-1384
%@ 2161-8720
%D 2023
%I Hans Publishing
%R 10.12677/ACM.2023.132190
%X 目的：探讨三阴性乳腺癌中信号转导及转录激活因子1 (STAT1)、趋化因子CXC配体9 (CXCL9)及雄激素受体(AR)的表达水平、相关性及其临床病理特征。方法：收集已经确诊并经过改良根治手术切除的三阴性乳腺癌(TNBC)病例114例，通过免疫组织化学染色(SP)的方法，测定STAT1、CXCL9及AR它们三者在TNBC中的表达情况、相关性分析及其与临床相关资料的关系。结果：STAT1、CXCL9及AR在三阴性乳腺癌中的阳性率分别为90.4% (103/114)、3.5% (4/114)及11.4% (13/114)；STAT1、CXCL9及AR它们三者表达不相关(P &gt; 0.05)；STAT1与年龄相关(P &lt; 0.05)，CXCL9与肿块的直径相关(P &lt; 0.05)，三者均与乳腺癌的组织学分级、淋巴结转移表达不相关(P &gt; 0.05)。结论：STAT1在三阴性乳腺癌(TNBC)中显著表达，并且与年龄相关，有望成为TNBC治疗及预后评价的重要靶标。<br />
Objective: To investigate the expression level, correlation and clinicopathological features of signal transduction and transcription activator 1 (STAT1), chemokine CXC ligand 9 (CXCL9) and androgen receptor (AR) in triple-negative breast cancer. Methods: A total of 114 cases of triple negative breast cancer (TNBC) were collected. The expression of STAT1, CXCL9 and AR in TNBC, correlation analysis and their relationship with clinical data were measured by immunohistochemical staining (SP). Results: The positive rates of STAT1, CXCL9 and AR in triple-negative breast cancer were 90.4% (103/114), 3.5% (4/114) and 11.4% (13/114), respectively. The expressions of STAT1, CXCL9 and AR were not correlated (P &gt; 0.05). STAT1 was significantly correlated with age (P &lt; 0.05), CXCL9 was significantly correlated with the diameter of the tumor (P &lt; 0.05), and all of them were not corre-lated with histological grade and lymph node metastasis expression of breast cancer (P &gt; 0.05). Conclusion: STAT1 is significantly expressed in triple negative breast cancer (TNBC), and it is relat-ed to age, which is expected to be an important target for TNBC treatment and prognosis evaluation.
%K 三阴性乳腺癌，STAT1，CXCL9，AR，预后<br>Triple Negative Breast Cancer
%K STAT1
%K CXCL9
%K AR
%K Prognosis
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=61122